BACKGROUND/AIMS: To evaluate the relationship of antiphospholipid antibodies and @entity715 in cirrhotics. METHODOLOGY: 22 cirrhotics without @entity715 (Group I), 18 with @entity715 (Group II) and 20 healthy controls (Group III) were enrolled. Anticardiolipin IgG and IgM antibody concentrations were measured by ELISA and @entity4555 by clotting. Groups were compared according to sex, age, etiology of @entity82 , prior intraabdominal surgery, Child groups, anticardiolipin IgG, IgM and @entity4555 . Then for all the 40 cirrhotics (Group IV) correlation was tested between anticardiolipin IgM, IgG, @entity4555 and @entity1 groups, etiology of @entity82 , sex and prior surgery. RESULTS: In Group I, anticardiolipin IgG concentration was 15.3 (15.9) GPL)/mL and IgM was 8.6 (6.5) @entity20096 /mL. In 6 (27.27%) anticardiolipin IgG, in 6 (27.27%) IgM and in 2 (9.09%) both were high. @entity4555 was positive in 7 (31.81%). In Group II anticardiolipin IgG concentration was 26.3 (14.7) GPL/mL and IgM was 15.1 (7.2) @entity20096 /mL. In 10 (55.55%) anticardiolipin IgG, in 13 (72.22%) IgM and in 9 (50%) both were high. @entity4555 was positive in 5 (27.77%). In Group III @entity4555 was positive in 1 (0.5%). Anticardiolipin IgG was 10.3 (5.9) GPL/mL, IgM 5 (3.6) @entity20096 /mL anticardiolipin IgM level was high in 1 (0.5%). Group I and II were similar with respect to @entity4555 , @entity1 groups, prior intraabdominal surgery and etiology of @entity82 . For anticardiolipin IgG and IgM there was a significant difference between Group I and II, I and III and II and III. In Group IV there was no correlation between prior abdominal surgery, @entity1 groups, sex, etiology and anticardiolipin IgG, IgM or @entity4555 . CONCLUSIONS: Anticardiolipin antibody concentrations were significantly higher in cirrhotics with @entity715 . Thus anticardiolipin antibodies may play a role in the development of @entity715 in @entity82 .

XXXX in cirrhotics: related with anticardiolipin antibodies?

@entity1 :: ('9606', 'Species') :: ['Child'] @entity82 :: ('MESH:D005355', 'Disease') :: ['cirrhosis'] @entity20096 :: ('4352', 'Gene') :: ['MPL'] @entity4555 :: ('MESH:C531622', 'Disease') :: ['lupus anticoagulant', 'Lupus anticoagulant'] @entity715 :: ('MESH:D013927', 'Disease') :: ['portal vein thrombosis']
@entity715 :: (MESH:D013927,Disease) :: ['Portal vein thrombosis']
